cbdMD, Inc. (YCBD) Q4 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon. Welcome to the CBDMD Inc. fourth quarter and fiscal 2023 earnings call and update. This afternoon, the company issued a press release that provided an overview of the results for its fourth quarter and 12-month fiscal period ended September 30th, 2023, which followed the filing of its annual report on Form 10-K. Today's conference call is being recorded and will be available online along with our earnings press release covering our financial results and non-GAAP presentations at cbdemd.com in accordance with CBDMD's retention policies. All participants on this call will be in listen-only mode. After the presentation, there'll be an opportunity to ask questions. To join the question queue, you may press star then one on your telephone keypad. At this time, I'd like to turn the conference over to Brad Whitford, this company's Vice President of Finance. Brad, please go ahead. Thank you, Gaylene, and thank you all for joining CBDMD's September 30th, 2023 fourth quarter and fiscal 2023 earnings call and update. On the call today, we also have Ronan Kennedy, our Interim CEO and Chief Financial Officer, and Dr. Sybil Swift, our Chief Science Officer. We'd like to remind everyone that various remarks without future expectations, plans, and prospects constitute forward-looking statements for purposes of safe harbor provisions under the Private Securities Litigation Reform Act of 1995. CBDMD cautions that these forward-looking statements are subject to risks and uncertainties that may cause our actual results to differ materially from those indicated. including risks described in the company's annual report on Form 10-K for the year ended September 30th, 2023, and our other filings with the SEC, all of which can be reviewed on the company's website at www.cbdmd...